Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
Motus GI Holdings, Inc. MOTS
$0.75
-$0.05 (-6.25%)
На 18:00, 12 мая 2023
Ранг: 3
Ключевые показатели
-
Marketcap
3641499.00000000
-
week52high
6.40
-
week52low
0.68
-
Revenue
592000
-
P/E TTM
0
-
Beta
1.90934200
-
EPS
-5.95000000
-
Last Dividend
0.00000000
-
Next Earnings Date
10 мая 2023 г. в 10:59
Описание компании
Motus GI Holdings, Inc., a medical technology company, develops Pure-Vu system, a medical device to facilitate the cleaning of a poorly prepared gastrointestinal tract during the colonoscopy and facilitates upper gastrointestinal endoscopy procedure. The company was incorporated in 2016 and is based in Fort Lauderdale, Florida.
Рекомендации
аналитиков
Рекомендации аналитиков
Grading company | New grade | Previous grade | Recommendation date |
---|---|---|---|
HC Wainwright & Co. | Buy | Buy | 15 авг 2022 г. |
HC Wainwright & Co. | Buy | Buy | 26 июл 2022 г. |
HC Wainwright & Co. | Buy | Buy | 16 мая 2022 г. |
HC Wainwright & Co. | Buy | Buy | 16 ноя 2020 г. |
H.C. Wainwright | Buy | 21 апр 2020 г. | |
Piper Sandler | Overweight | Overweight | 15 ноя 2022 г. |
HC Wainwright & Co. | Buy | Buy | 15 ноя 2022 г. |
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Новостная лента
компании
Insider Summary
Insider Summary
Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
---|---|---|---|---|
Nelson Sonja | A | 50000 | 50000 | 10 февр 2022 г. |
Pruden Gary J | A | 50000 | 50000 | 10 февр 2022 г. |
Hochman David P | A | 50000 | 50000 | 10 февр 2022 г. |
Korangy Shervin J | A | 50000 | 50000 | 10 февр 2022 г. |
Sherman Darren | A | 50000 | 50000 | 10 февр 2022 г. |
Moran Timothy P. | A | 175000 | 175000 | 10 февр 2022 г. |
Moran Timothy P. | A | 657701 | 175000 | 10 февр 2022 г. |
Pomeranz Mark | A | 95000 | 95000 | 10 февр 2022 г. |
Pomeranz Mark | A | 259857 | 95000 | 10 февр 2022 г. |
Taylor Andrew Lawrence | A | 95000 | 95000 | 10 февр 2022 г. |
Новостная лента
Motus GI Holdings, Inc. (MOTS) Reports Q1 Loss, Lags Revenue Estimates
Zacks Investment Research
10 мая 2023 г. в 20:31
Motus GI Holdings, Inc. (MOTS) came out with a quarterly loss of $0.65 per share versus the Zacks Consensus Estimate of a loss of $1.06. This compares to loss of $1.80 per share a year ago.
Motus GI Holdings, Inc. (MOTS) Reports Q4 Loss, Lags Revenue Estimates
Zacks Investment Research
31 мар 2023 г. в 19:05
Motus GI Holdings, Inc. (MOTS) delivered earnings and revenue surprises of 36.80% and 72.75%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Motus GI Holdings, Inc. (MOTS) Reports Q3 Loss, Misses Revenue Estimates
Zacks Investment Research
14 ноя 2022 г. в 21:03
Motus GI Holdings, Inc. (MOTS) delivered earnings and revenue surprises of 9.63% and 14.72%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Motus GI Holdings, Inc. (MOTS) Q3 2022 Earnings Call Transcript
Seeking Alpha
14 ноя 2022 г. в 18:44
Motus GI Holdings, Inc. (NASDAQ:MOTS ) Q3 2022 Earnings Conference Call November 14, 2022 4:30 PM ET Company Participants Garth Russell - Managing Director-LifeSci Advisors, LLC Tim Moran - Chief Executive Officer Andrew Taylor - Chief Financial Officer Mark Pomeranz - President & Chief Operating Officer Conference Call Participants Steve Lichtman - Oppenheimer and Co. Ben Haynor - Alliance Global Partners Operator Ladies and gentlemen, thank you for standing by, and welcome to the Motus GI Holdings, Inc. Third Quarter 2022 Financial and Operational Update. At this time, all participants are in a listen-only mode.
Motus GI to Release Third Quarter Results and Provide a Business Update on November 14
GlobeNewsWire
31 окт 2022 г. в 16:05
FORT LAUDERDALE, Fla., Oct. 31, 2022 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc., (NASDAQ: MOTS) ("Motus GI" or the "Company"), a medical technology company providing endoscopy solutions that improve clinical outcomes and enhance the cost-efficiency associated with the diagnosis and management of gastrointestinal conditions, announced today that the Company will release its third quarter financial results on Monday, November 14, 2022, after the market close. Management will host a conference call and webcast at 4:30 p.m. ET to discuss the results and provide updates on recent corporate developments.